ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function
Martina de Majo, Simon D Topp, Bradley N Smith, Agnes L Nishimura, Han-Jou Chen, Athina Soragia Gkazi, Jack Miller, Chun Hao Wong, Caroline Vance, Frank Baas, Anneloor L M A Ten Asbroek, Kevin P Kenna, Nicola Ticozzi, Alberto Garcia Redondo, Jesús Esteban-Pérez, Cinzia Tiloca, Federico Verde, Stefano Duga, Karen E Morrison, Pamela J Shaw, Janine Kirby, Martin R Turner, Kevin Talbot, Orla Hardiman, Jonathan D Glass, Jacqueline de Belleroche, Cinzia Gellera, Antonia Ratti, Ammar Al-Chalabi, Robert H Brown, Vincenzo Silani, John E Landers, Christopher E Shaw, Martina de Majo, Simon D Topp, Bradley N Smith, Agnes L Nishimura, Han-Jou Chen, Athina Soragia Gkazi, Jack Miller, Chun Hao Wong, Caroline Vance, Frank Baas, Anneloor L M A Ten Asbroek, Kevin P Kenna, Nicola Ticozzi, Alberto Garcia Redondo, Jesús Esteban-Pérez, Cinzia Tiloca, Federico Verde, Stefano Duga, Karen E Morrison, Pamela J Shaw, Janine Kirby, Martin R Turner, Kevin Talbot, Orla Hardiman, Jonathan D Glass, Jacqueline de Belleroche, Cinzia Gellera, Antonia Ratti, Ammar Al-Chalabi, Robert H Brown, Vincenzo Silani, John E Landers, Christopher E Shaw
Abstract
Mutations in TANK binding kinase 1 (TBK1) have been linked to amyotrophic lateral sclerosis. Some TBK1 variants are nonsense and are predicted to cause disease through haploinsufficiency; however, many other mutations are missense with unknown functional effects. We exome sequenced 699 familial amyotrophic lateral sclerosis patients and identified 16 TBK1 novel or extremely rare protein-changing variants. We characterized a subset of these: p.G217R, p.R357X, and p.C471Y. Here, we show that the p.R357X and p.G217R both abolish the ability of TBK1 to phosphorylate 2 of its kinase targets, IRF3 and optineurin, and to undergo phosphorylation. They both inhibit binding to optineurin and the p.G217R, within the TBK1 kinase domain, reduces homodimerization, essential for TBK1 activation and function. Finally, we show that the proportion of TBK1 that is active (phosphorylated) is reduced in 5 lymphoblastoid cell lines derived from patients harboring heterozygous missense or in-frame deletion TBK1 mutations. We conclude that missense mutations in functional domains of TBK1 impair the binding and phosphorylation of its normal targets, implicating a common loss of function mechanism, analogous to truncation mutations.
Keywords: ALS; FTD; Familial ALS; TBK1; WES.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
- Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293–299.
- Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.-F., Wang Q., Krueger B.J., Ren Z., Keebler J., Han Y., Levy S.E., Boone B.E., Wimbish J.R., Waite L.L., Jones A.L., Carulli J.P., Day-Williams A.G., Staropoli J.F., Xin W.W., Chesi A., Raphael A.R., McKenna-Yasek D., Cady J., Vianney de Jong J.M.B., Kenna K.P., Smith B.N., Topp S., Miller J., Gkazi A., FALS Sequencing Consortium. Al-Chalabi A., van den Berg L.H., Veldink J., Silani V., Ticozzi N., Shaw C.E., Baloh R.H., Appel S., Simpson E., Lagier-Tourenne C., Pulst S.M., Gibson S., Trojanowski J.Q., Elman L., McCluskey L., Grossman M., Shneider N.A., Chung W.K., Ravits J.M., Glass J.D., Sims K.B., Van Deerlin V.M., Maniatis T., Hayes S.D., Ordureau A., Swarup S., Landers J., Baas F., Allen A.S., Bedlack R.S., Harper J.W., Gitler A.D., Rouleau G.A., Brown R., Harms M.B., Cooper G.M., Harris T., Myers R.M., Goldstein D.B. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436–1441.
- Freischmidt A., Müller K., Ludolph A.C., Weishaupt J.H., Andersen P.M. Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia. JAMA Neurol. 2016;74:110–113.
- Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., Müller K., Marroquin N., Nordin F., Hübers A., Weydt P., Pinto S., Press R., Millecamps S., Molko N., Bernard E., Desnuelle C., Soriani M.-H., Dorst J., Graf E., Nordström U., Feiler M.S., Putz S., Boeckers T.M., Meyer T., Winkler A.S., Winkelman J., de Carvalho M., Thal D.R., Otto M., Brännström T., Volk A.E., Kursula P., Danzer K.M., Lichtner P., Dikic I., Meitinger T., Ludolph A.C., Strom T.M., Andersen P.M., Weishaupt J.H. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631–636.
- Gijselinck I., Van Mossevelde S., Van Der Zee J., Sieben A., Philtjens S., Heeman B., Engelborghs S., Vandenbulcke M., De Baets G., B??umer V., Cuijt I., Van Den Broeck M., Peeters K., Mattheijssens M., Rousseau F., Vandenberghe R., De Jonghe P., Cras P., De Deyn P.P., Martin J.J., Cruts M., Van Broeckhoven C. Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology. 2015;85:2116–2125.
- Heo J.-M.M., Ordureau A., Paulo J.A.A., Rinehart J., Harper J.W.W. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell. 2015;60:1–14.
- Jian X., Boerwinkle E., Liu X. In silico prediction of splice-altering single nucleotide variants in the human genome. Nucleic Acids Res. 2014;42:13534–13544.
- Kim Y.-E., Oh K.-W., Noh M.-Y., Nahm M., Park J., Lim S.M., Jang J.-H., Cho E.-H., Ki C.-S., Lee S., Kim S.H. Genetic and functional analysis of TBK1 variants in Korean patients with sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2016;50:170.e1–170.e6.
- Li F., Xie X., Wang Y., Liu J., Cheng X., Guo Y., Gong Y., Hu S., Pan L. Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins. Nat. Commun. 2016;7:12708.
- Li J., Li J., Miyahira A., Sun J., Liu Y., Cheng G., Liang H. Crystal structure of the ubiquitin-like domain of human TBK1. Protein Cell. 2012;3:383–391.
- Ma X., Helgason E., Phung Q.T., Quan C.L., Iyer R.S., Lee M.W., Bowman K.K., Starovasnik M.A., Dueber E.C. Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proc. Natl. Acad. Sci. 2012;109:9378–9383.
- Manichaikul A., Mychaleckyj J.C., Rich S.S., Daly K., Sale M., Chen W.M. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26:2867–2873.
- Morgan S., Orrell R.W. Pathogenesis of amyotrophic lateral sclerosis. Br. Med. Bull. 2016;119:87–97.
- Pottier C., Bieniek K.F., Finch N., van de Vorst M., Baker M., Perkersen R., Brown P., Ravenscroft T., van Blitterswijk M., Nicholson A.M., DeTure M., Knopman D.S., Josephs K.A., Parisi J.E., Petersen R.C., Boylan K.B., Boeve B.F., Graff-Radford N.R., Veltman J.A., Gilissen C., Murray M.E., Dickson D.W., Rademakers R. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 2015;130:77–92.
- Pozzi L., Valenza F., Mosca L., Dal Mas A., Domi T., Romano A., Tarlarini C., Falzone Y.M., Tremolizzo L., Sorarù G., Cerri F., Ferraro P.M., Basaia S., Agosta F., Fazio R., Comola M., Comi G., Ferrari M., Quattrini A., Lunetta C., Penco S., Bonanomi D., Carrera P., Riva N. TBK1 mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation. J. Neurol. Neurosurg. Psychiatry. 2017;88:869–875.
- Richter B., Sliter D.A., Herhaus L., Stolz A., Wang C., Beli P., Zaffagnini G., Wild P., Martens S., Wagner S.A., Youle R.J., Dikic I. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2016;113:4039–4044.
- Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., Tinevez J.-Y., White D.J., Hartenstein V., Eliceiri K., Tomancak P., Cardona A. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676–682.
- Scotter E.L., Vance C., Nishimura A.L., Lee Y.-B.Y., Chen H.H.-J., Urwin H., Sardone V., Mitchell J.C., Rogelj B., Rubinsztein D.C., Shaw C.E. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 2014;127:1263–1278.
- Taylor P., Brown R.H., Cleveland D.W. Decoding ALS: from genes to mechanism. Nature. 2016;539:197–206.
- Tiwari A., Xu Z., Hayward L.J. Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis. J. Biol. Chem. 2005;280:29771–29779.
- Tsai P.-C., Liu Y.-C., Lin K.-P., Liu Y.-T., Liao Y.-C., Hsiao C.-T., Soong B.-W., Yip P.-K., Lee Y.-C. Mutational analysis of TBK1 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2016;40:191.e11–191.e16.
- Tu D., Zhu Z., Zhou A.Y., Yun C.H., Lee K.E., Toms A.V., Li Y., Dunn G.P., Chan E., Thai T., Yang S., Ficarro S.B., Marto J.A., Jeon H., Hahn W.C., Barbie D.A., Eck M.J. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 2013;3:747–758.
- van der Zee J., Gijselinck I., Van Mossevelde S., Perrone F., Dillen L., Heeman B., Bäumer V., Engelborghs S., De Bleecker J., Baets J., Gelpi E., Rojas-García R., Clarimón J., Lleó A., Diehl-Schmid J., Alexopoulos P., Perneczky R., Synofzik M., Just J., Schöls L., Graff C., Thonberg H., Borroni B., Padovani A., Jordanova A., Sarafov S., Tournev I., de Mendonça A., Miltenberger-Miltényi G., Simões do Couto F., Ramirez A., Jessen F., Heneka M.T., Gómez-Tortosa E., Danek A., Cras P., Vandenberghe R., De Jonghe P., De Deyn P.P., Sleegers K., Cruts M., Van Broeckhoven C., Goeman J., Nuytten D., Smets K., Robberecht W., Damme P., Van Bleecker J., De Santens P., Dermaut B., Versijpt J., Michotte A., Ivanoiu A., Deryck O., Bergmans B., Delbeck J., Bruyland M., Willems C., Salmon E., Pastor P., Ortega-Cubero S., Benussi L., Ghidoni R., Binetti G., Hernández I., Boada M., Ruiz A., Sorbi S., Nacmias B., Bagnoli S., Sorbi S., Sanchez-Valle R., Llado A., Santana I., Rosário Almeida M., Frisoni G.B., Maetzler W., Matej R., Fraidakis M.J., Kovacs G.G., Fabrizi G.M., Testi S. TBK1 mutation spectrum in an extended european patient cohort with frontotemporal dementia and amyotrophic lateral sclerosis. Hum. Mutat. 2017;38:297–309.
- Wang K., Li M., Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:1–7.
- Weidberg H., Elazar Z. TBK1 mediates crosstalk between the innate immune response and autophagy. Sci. Signal. 2011;4:pe39.
- Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., Richter B., Korac J., Waidmann O., Choudhary C., Dotsch V., Bumann D., Dikic I., Dötsch V., Bumann D., Dikic I., Nakatogawa H., Suzuki K., Kamada Y., Ohsumi Y., Yang Z., Klionsky D.J., Levine B., Mizushima N., Virgin H.W., Deretic V., Kirkin V., McEwan D.G., Novak I., Dikic I., Kraft C., Peter M., Hofmann K., McEwan D.G., Dikic I., Novak I., Kirkin V., Pankiv S., Behrends C., Sowa M.E., Gygi S.P., Harper J.W., Wagner S., Morton S., Hesson L., Peggie M., Cohen P., Clark K., Plater L., Peggie M., Cohen P., Radtke A.L., Delbridge L.M., Balachandran S., Barber G.N., O’Riordan M.X., Thurston T.L., Ryzhakov G., Bloor S., Muhlinen N., von Randow F., Knodler L.A., Perrin A.J., Jiang X., Birmingham C.L., So N.S., Brumell J.H., Beuzón C.R., Zheng Y.T., Cemma M., Kim P.K., Brumell J.H., Stehmeier P., Muller S., Jiang H., Cheng D., Liu W., Peng J., Feng J., Cherra S.J., Ikeda F., Crosetto N., Dikic I. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333:228–233.
- Yang J., Benyamin B., Mcevoy B.P., Gordon S., Henders A.K., Dale R., Madden P.A., Heath A.C., Martin N.G., Montgomery G.W., Goddard M.E., Visscher P.M. Common SNPs explain a large proportion of heritability for human height. Nat. Genet. 2011;42:565–569.
Source: PubMed